Literature DB >> 29871944

Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Katherine E Squires1, Carolina Montañez-Miranda1, Rushika R Pandya1, Matthew P Torres1, John R Hepler2.   

Abstract

Regulators of G protein signaling (RGS) proteins modulate the physiologic actions of many neurotransmitters, hormones, and other signaling molecules. Human RGS proteins comprise a family of 20 canonical proteins that bind directly to G protein-coupled receptors/G protein complexes to limit the lifetime of their signaling events, which regulate all aspects of cell and organ physiology. Genetic variations account for diverse human traits and individual predispositions to disease. RGS proteins contribute to many complex polygenic human traits and pathologies such as hypertension, atherosclerosis, schizophrenia, depression, addiction, cancers, and many others. Recent analysis indicates that most human diseases are due to extremely rare genetic variants. In this study, we summarize physiologic roles for RGS proteins and links to human diseases/traits and report rare variants found within each human RGS protein exome sequence derived from global population studies. Each RGS sequence is analyzed using recently described bioinformatics and proteomic tools for measures of missense tolerance ratio paired with combined annotation-dependent depletion scores, and protein post-translational modification (PTM) alignment cluster analysis. We highlight selected variants within the well-studied RGS domain that likely disrupt RGS protein functions and provide comprehensive variant and PTM data for each RGS protein for future study. We propose that rare variants in functionally sensitive regions of RGS proteins confer profound change-of-function phenotypes that may contribute, in newly appreciated ways, to complex human diseases and/or traits. This information provides investigators with a valuable database to explore variation in RGS protein function, and for targeting RGS proteins as future therapeutic targets.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29871944      PMCID: PMC5989036          DOI: 10.1124/pr.117.015354

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  378 in total

1.  Structure, alternative splicing, and expression of the human RGS9 gene.

Authors:  K Zhang; K A Howes; W He; J D Bronson; M J Pettenati; C Chen; K Palczewski; T G Wensel; W Baehr
Journal:  Gene       Date:  1999-11-15       Impact factor: 3.688

2.  Large-scale genome-wide association study of Asian population reveals genetic factors in FRMD4A and other loci influencing smoking initiation and nicotine dependence.

Authors:  Dankyu Yoon; Young-Jin Kim; Wen-Yan Cui; Andrew Van der Vaart; Yoon Shin Cho; Jong-Young Lee; Jennie Z Ma; Thomas J Payne; Ming D Li; Taesung Park
Journal:  Hum Genet       Date:  2011-10-18       Impact factor: 4.132

3.  Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells.

Authors:  C Huang; J R Hepler; A G Gilman; S M Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

4.  Evolution of the regulators of G-protein signaling multigene family in mouse and human.

Authors:  David A Sierra; Debra J Gilbert; Deborah Householder; Nick V Grishin; Kan Yu; Pallavi Ukidwe; Sheryll A Barker; Wei He; Theodore G Wensel; Glen Otero; Greg Brown; Neal G Copeland; Nancy A Jenkins; Thomas M Wilkie
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

5.  RGS3 and RGS4 are GTPase activating proteins in the heart.

Authors:  S Zhang; N Watson; J Zahner; J N Rottman; K J Blumer; A J Muslin
Journal:  J Mol Cell Cardiol       Date:  1998-02       Impact factor: 5.000

6.  Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells.

Authors:  Shelley B Hooks; Phillip Callihan; Molly K Altman; Jillian H Hurst; Mourad W Ali; Mandi M Murph
Journal:  Mol Cancer       Date:  2010-11-02       Impact factor: 27.401

7.  Pivotal Role of Regulator of G-protein Signaling 12 in Pathological Cardiac Hypertrophy.

Authors:  Jia Huang; Lijuan Chen; Yuyu Yao; Chengchun Tang; Jiandong Ding; Cong Fu; Hongliang Li; Genshan Ma
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

8.  RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling.

Authors:  Helen Mao; Qingshi Zhao; Mireille Daigle; Mohammad H Ghahremani; Peter Chidiac; Paul R Albert
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

9.  Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure.

Authors:  K Mary Tang; Guang-rong Wang; Ping Lu; Richard H Karas; Mark Aronovitz; Scott P Heximer; Kevin M Kaltenbronn; Kendall J Blumer; David P Siderovski; Yan Zhu; Michael E Mendelsohn; Mary Tang; Guang Wang
Journal:  Nat Med       Date:  2003-11-09       Impact factor: 53.440

10.  Association between regulator of G protein signaling 9-2 and body weight.

Authors:  Jeffrey L Waugh; Jeremy Celver; Meenakshi Sharma; Robert L Dufresne; Dimitra Terzi; S Craig Risch; William G Fairbrother; Rachael L Neve; John P Kane; Mary J Malloy; Clive R Pullinger; Harvest F Gu; Christos Tsatsanis; Steven P Hamilton; Stephen J Gold; Venetia Zachariou; Abraham Kovoor
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

View more
  29 in total

1.  Residue-level determinants of RGS R4 subfamily GAP activity and specificity towards the Gi subfamily.

Authors:  Ali Asli; Sabreen Higazy-Mreih; Meirav Avital-Shacham; Mickey Kosloff
Journal:  Cell Mol Life Sci       Date:  2021-07-22       Impact factor: 9.261

Review 2.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

Review 3.  Regulators of G Protein Signaling in Analgesia and Addiction.

Authors:  Farhana Sakloth; Claire Polizu; Feodora Bertherat; Venetia Zachariou
Journal:  Mol Pharmacol       Date:  2020-05-30       Impact factor: 4.436

4.  Probing the mutational landscape of regulators of G protein signaling proteins in cancer.

Authors:  Vincent DiGiacomo; Marcin Maziarz; Alex Luebbers; Jillian M Norris; Pandu Laksono; Mikel Garcia-Marcos
Journal:  Sci Signal       Date:  2020-02-04       Impact factor: 8.192

Review 5.  Genetic intolerance analysis as a tool for protein science.

Authors:  Geoffrey C Li; Eliot T C Forster-Benson; Charles R Sanders
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-09-05       Impact factor: 3.747

Review 6.  Mechanisms and Regulation of Neuronal GABAB Receptor-Dependent Signaling.

Authors:  Timothy R Rose; Kevin Wickman
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 7.  RGS14 Regulation of Post-Synaptic Signaling and Spine Plasticity in Brain.

Authors:  Nicholas H Harbin; Sara N Bramlett; Carolina Montanez-Miranda; Gizem Terzioglu; John R Hepler
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

Review 8.  Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.

Authors:  Fanglin Guan; Tong Ni; Weili Zhu; L Keoki Williams; Long-Biao Cui; Ming Li; Justin Tubbs; Pak-Chung Sham; Hongsheng Gui
Journal:  Mol Psychiatry       Date:  2021-06-30       Impact factor: 15.992

9.  PI3K/ NF-κB-dependent TNF-α and HDAC activities facilitate LPS-induced RGS10 suppression in pulmonary macrophages.

Authors:  Faris Almutairi; Samantha L Tucker; Demba Sarr; Balázs Rada
Journal:  Cell Signal       Date:  2021-07-31       Impact factor: 4.850

10.  Short stature and combined immunodeficiency associated with mutations in RGS10.

Authors:  Ivan K Chinn; Zhihui Xie; Eunice C Chan; Bianca M Nagata; Alexey Koval; Wei-Sheng Chen; Fan Zhang; Sundar Ganesan; Diana N Hong; Motoshi Suzuki; Glenn Nardone; Ian N Moore; Vladimir L Katanaev; Andrea E Balazs; Chengyu Liu; James R Lupski; Jordan S Orange; Kirk M Druey
Journal:  Sci Signal       Date:  2021-07-27       Impact factor: 9.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.